Mother Infant Nutrition Study
Launched by UNIVERSITY OF TEXAS AT AUSTIN · Oct 16, 2019
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The Institute of Medicine (IOM) recommendations were established with limited evidence showing how the pattern of weight gain is associated with short-and long-term health of mothers and their children. Previous studies evaluated the impact of overall gestational weight gain pattern across gestation using latent class analysis and others have evaluated maternal weight change pattern-by trimester or early/late pregnancy-on offspring size and adiposity. However, it remains unclear if there are weight gain trajectories or specific periods of weight gain that are associated with greater adiposi...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. \<16 weeks gestation
- • 2. Age \>18 years old
- • 3. BMI \<35 kg/m2
- • 4. Width \<48 cm
- Exclusion Criteria:
- • 1. Diabetes
- • 2. Claustrophobia
- • 3. Recent weight loss of \>5% of body weight before pregnancy
- • 4. Weight-loss related surgery
- • 5. Currently breastfeeding
- • 6. Smoking
- • 7. Presence of any mechanically or magnetically activated implants, or any other contraindication for MRI
About University Of Texas At Austin
The University of Texas at Austin, a leading research institution, is dedicated to advancing knowledge and innovation in the field of healthcare through rigorous clinical trials. Known for its commitment to scientific excellence, the university leverages its diverse expertise and cutting-edge facilities to conduct research that addresses critical health challenges. Collaborating with a multidisciplinary team of researchers, clinicians, and students, the University of Texas at Austin aims to translate scientific discoveries into effective treatments and interventions, ultimately enhancing patient outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Austin, Texas, United States
Austin, Texas, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials